[Effect of semaglutide on serum metabolomics in obese patients with type 2 diabetes mellitus complicated with metabolic-associated fatty liver disease].

Siqi Niu、Wang Cx、Y. B. Zhao、Dehong Wu、Kelu Yang

2025PubMed被引 1

摘要

Semaglutide alters the serum metabolite levels in obese patients with T2DM complicated by MAFLD.

引用本文（GB/T 7714）

Siqi Niu, Wang Cx, Y. B. Zhao, 等. [Effect of semaglutide on serum metabolomics in obese patients with type 2 diabetes mellitus complicated with metabolic-associated fatty liver disease].[J]. PubMed, 2025.

引文网络

参考文献与被引分析加载中…

DOI：https://doi.org/10.3760/cma.j.cn112138-20250424-00235

本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。